|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Dockets Entered On October 31, 2006
|
|
|
|
|
|
|
|
|
|
|
| Docket
#
|
| Title
|
|
|
|
|
|
|
| 1995N-0294
|
| Quality/fill container;
common or unusual name regulations
|
|
|
|
|
| 2000E-1252
|
| Patent Extension Alamast
#5,034,230
|
|
|
|
|
| 2003F-0535
|
| Chlorine Dioxide (FAP
4A4751)
|
|
|
|
|
| 2005N-0403
|
| Requirements for Foreign
and Domestic Establishment Registration and Listing for Human Drugs,
Including Drugs that are Regulated Under a Biologics License Application,
and Animal Drugs
|
|
|
|
|
| 2006D-0331
|
| Guidance for Institutional
Review Boards, Clinical Investigators, and Sponsors; Exception from
Informed Consent Requirements for Emergency Research
|
|
|
|
|
| 2006D-0363
|
| Guidance for Industry and
Food and Drug Administration Staff; Draft Class II Special Controls
Guidance Document: Absorbable Hemostatic Device
|
|
|
|
|
| 2006D-0383
|
| Characterization and
Qualification of Cell Substrates and Other Biological Starting Materials
Used in the Production of Viral Vaccines for the Prevention and Treatment
of Infectious Diseases
|
|
|
|
|
| 2006N-0107
|
| FDA-Regulated Products
Containing Nanotechnology Materials
|
|
|
|
|
| 2006N-0184
|
| Agency Information
Collection Activities; Proposed Collection; Comment Request;
Investigational Device Exemptions Reports and Records
|
|
|
|
|
| 2006N-0220
|
| Agency Information
Collection Activities; Proposed Collection; Comment Request;
Administrative Detention and Banned Medical Devices
|
|
|
|
|
| 2006N-0239
|
| Agency Information
Collection Activities; Proposed Collection; Comment Request; Infectious
Disease Issues in Xenotransplantation
|
|
|
|
|
| 2006N-0292
|
| Unique Device
Identification
|
|
|
|
|
| 2006N-0352
|
| Comments Relating to the
September 6 & 7, 2006 Joint Panel Meeting on Dental Amalgam
|
|
|
|
|
| 2006N-0362
|
| General and Plastic
Surgery Devices; Reclassification of the Absorbable Hemostatic
Device
|
|
|
|
|
| 2006N-0421
|
| Agency
Information Collection Activities; Proposed Collection; Comment Request;
Biological Products: Reporting of Biological Product Deviations in
Manufacturing; Forms FDA 3486 and 3486A
|
|
|
|
|
|
|
|
|
| 2006N-0426
|
| Agency Information
Collection Activities; Proposed Collection; Comment Request; Medical
Device User Fee and Modernization Act Small Business Qualification
Certification (Form FDA 3602)
|
|
|
|
|
| 2006P-0394
|
| Revise the labeling
requirements for eggs sold in the United States
|
|
|
|
|
| 1995N-0294
|
| Quality/fill container;
common or unusual name regulations
|
|
|
|
|
| ACK 1
|
| FDA/DDM to the Grocery
Manufacturers Association
|
| Vol
#:
|
| 6
|
|
|
|
|
| CP 1
|
| Grocery Manufacturers
Association
|
| Vol
#:
|
| 6
|
|
|
|
|
| 2000E-1252
|
| Patent Extension
Alamast #5,034,230
|
|
|
|
|
| LET 4
|
| FDA/CDER to the U.S.
Patent and Trademark Office
|
| Vol
#:
|
| 1
|
|
|
|
|
| 2003F-0535
|
| Chlorine Dioxide (FAP
4A4751)
|
|
|
| LET 1
|
| FDA/CFSAN
|
| Vol
#:
|
| 1
|
|
|
|
|
| 2005N-0403
|
| Requirements
for Foreign and Domestic Establishment Registration and Listing for Human
Drugs, Including Drugs that are Regulated Under a Biologics License
Application, and Animal Drugs
|
|
|
|
|
|
|
|
|
|
|
| NEC 1
|
| FDA
|
| Vol
#:
|
| 3
|
|
|
|
|
| 2006D-0331
|
| Guidance for
Institutional Review Boards, Clinical Investigators, and Sponsors;
Exception from Informed Consent Requirements for Emergency Research
|
|
|
|
|
| C 9
|
| Federation of American
Hospitals
|
| Vol
#:
|
| 3
|
|
|
|
|
| C 10
|
| Council on Governmental
Relations
|
| Vol
#:
|
| 3
|
|
|
|
|
| EC 48
|
| Society for Academic
Emergency Medicine
|
| Vol
#:
|
| 2
|
|
|
|
|
| EC 49
|
| Novo Nordisk Inc
|
| Vol
#:
|
| 2
|
|
|
|
|
| EC 50
|
| University of Pennsylvania
Dept. of Emerg. Med
|
| Vol
#:
|
| 2
| |
